Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
Privacy breaches have become increasingly commonplace as businesses of all sizes grapple with how to keep customer information secure and what to do when...
Facial recognition technologies seem likely to become an increasingly commonplace part of travel with scans for boarding passes, security clearance, customs review, and baggage...
Bill C-18, the Online News Act, has been at the centre of growing firestorm in Canada following reports that Google has begun testing the...